Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Anxiety
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Anxiety
    TopAbstracts in Anxiety 09/03/2008 - (DGNews)
    Long-Term Antidepressant Treatment Without Active Management Hardly Induces Remission: Presented at ECNP - (DGNews)
    TopAbstracts in Anxiety 08/20/2008 - (DGNews)
    Voluntary Exercise Does Not Appear to Alleviate Anxiety, Depression - (DGNews)
    TopAbstracts in Anxiety 08/06/2008 - (DGNews)

    News archive

     Recent webcasts/CME - Anxiety
  • Understanding and Managing the Fibromyalgia Syndrome
  • Prevalence and Associated Factors for Suicidal Ideation and Behaviors in Obsessive-Compulsive Disorder

    Webcasts/CME archive

     Recent cases - Anxiety
      Recurrence of Suicidal Ideation Due to Treatment with Antidepressants in Anxiety Disorder: A Case Report
      Persistent Tardive Rebound Panic Disorder, Rebound Anxiety and Insomnia Following Paroxetine Withdrawal: a Review of Rebound-Withdrawal Phenomena
      Olfactory Reference Syndrome: Diagnostic Criteria and Differential Diagnosis
      Comedication with Sertraline and Phenprocoumon in Two Patients with Anxiety Disorders
      Self-Hypnosis for Anxiety Associated with Severe Asthma: A Case Report

      Cases archive
        




      my personal edition > anxiety > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      Sertraline Effective for Treating Social Anxiety Disorder: Presented at ADAA

      By Alison Palkhivala

      TORONTO, ON -- March 31, 2003 -- Sertraline (Zoloft) helps improve quality of life and functioning in patients with social anxiety disorder, especially among patients with severe impairment.

      Michael Liebowitz, MD, from the Anxiety Disorders Clinic, New York State Psychiatric Institute, New York, presented the findings here in a poster on March 29th at the 23rd Annual Conference of the Anxiety Disorders Association of America (ADAA).
      Dr. Liebowitz and colleagues randomized 415 outpatients with social anxiety disorder to 12 weeks of therapy with 50 to 200 mg/day of sertraline or a placebo. They assessed patients' quality of life and level of functioning using the Quality of Life, Enjoyment, and Satisfaction scale (Q-LES-Q), the Sheehan disability inventory (SDI) and the Endicott work productivity score (EWP).

      At baseline, 32% of patients had normal scores on the Q-LES-Q. By the end of the 12 weeks, 61% of patients taking sertraline and 46% of those on placebo had normal scores on this scale (P=0.016). Among patients who were more than one standard deviation below the community mean at baseline, 49% had normal scores by week 12 in the sertraline group, compared with 29% in the placebo group (P=0.0273).

      Sertraline therapy also resulted in significant improvement in the SDI compared with placebo, and there was a trend toward more improvement in the EWP in those taking sertraline compared with placebo.

      Dr. Liebowitz concluded that patients who are chronically ill with social anxiety disorder -- even for as long as 20 years -- can respond to 12 weeks of treatment with sertraline and improve their ability to function as well as the way they feel.


      [Study title: Efficacy of Sertraline in Improving Disability and Quality of Life Impairment in Severe Social Anxiety Disorder. P117]



      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send